Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder

Clinical trial NCT00481325 · COMPLETED

Trial details

NCT number: NCT00481325
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Generalized Anxiety Disorder

Start date: 2007-07-01
Primary completion: 2008-03-01
Enrollment: 260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.